Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Clinical trial NCT02392377 · TERMINATED

Trial details

NCT number: NCT02392377
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IB Esophageal Adenocarcinoma Stage IIA Esophageal Adenocarcinoma Stage IIB Esophageal Adenocarcinoma Stage IIIA Esophageal Adenocarcinoma Stage IIIB Esophageal Adenocarcinoma Stage IIIC Esophageal Adenocarcinoma

Start date: 2015-02-01
Primary completion: 2015-12-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.